Dexus healthcare fund adds Melbourne life science asset to potfolio

Dexus healthcare fund adds Melbourne life science asset to potfolio

Dexus Healthcare Property Fund is acquiring large-scale life science asset in Melbourne’s premier Biomedical Precinct.

Dexus Healthcare Property Fund (DHPF) has agreed to acquire Manning Building and Building 4, 399 Royal Parade, Parkville (Parkville) via an off-market process for A$138.7 million.

Located within the Melbourne Biomedical Precinct, the property comprises two of the five buildings at Monash University’s Parkville Campus which is home to Monash’s Faculty of Pharmacy and Pharmaceutical Science. The Faculty is ranked second in the world for pharmacy and pharmacology research.

READ ALSO : Unitholders approve merger of AMP Capital, Dexus funds

The property is 100% leased to Monash University with a Weighted Average Lease Expiry of 12.4 years.

“This Parkville acquisition adds another large-scale, income-producing asset located in a world-class biomedical precinct to DHPF’s portfolio. This transaction continues our strategy to grow and diversify DHPF through the acquisition of high-quality developments and stabilised healthcare assets. There are further opportunities in Brisbane and Perth currently under review,” said Deborah Coakley, Dexus Executive General Manager, Funds Management.

”This acquisition supports the growth of DHPF’s portfolio to over A$1.0 billion and follows the recent completion of North Shore Health Hub, DHPF’s premium healthcare facility located in the North Shore Hospital precinct in St Leonards, and the acquisition of Australian Bragg Centre, the state-of-the-art clinical and research facility located within Adelaide’s BioMed City precinct, acquired in HY21,” said Dexus in a statement.

Settlement of the Parkville acquisition is expected to occur on 12 May 2021.